Everest Organics Limited (EVERESTO.BO)
INR 257.5
(4.99%)
INR 257.5
(4.99%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 146.43 Million INR | 25.69% |
| 2022 | 116.5 Million INR | 6.05% |
| 2021 | 109.85 Million INR | 88.94% |
| 2020 | 58.14 Million INR | 26.06% |
| 2019 | 46.12 Million INR | -4.57% |
| 2018 | 48.33 Million INR | -25.1% |
| 2017 | 64.52 Million INR | 35.41% |
| 2016 | 47.65 Million INR | -65.54% |
| 2015 | 138.31 Million INR | 22.56% |
| 2014 | 112.85 Million INR | 11.67% |
| 2013 | 101.05 Million INR | 115.88% |
| 2012 | 46.81 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 143.26 Million INR | -2.16% |
| 2023 Q4 | 146.43 Million INR | 13.58% |
| 2023 Q1 | 105.1 Million INR | -9.79% |
| 2023 FY | 146.43 Million INR | 25.69% |
| 2023 Q3 | 128.92 Million INR | 39.36% |
| 2023 Q2 | 92.51 Million INR | -11.98% |
| 2022 Q3 | 121.34 Million INR | -5.88% |
| 2022 FY | 116.5 Million INR | 6.05% |
| 2022 Q2 | 128.92 Million INR | -5.04% |
| 2022 Q1 | 135.76 Million INR | 23.58% |
| 2022 Q4 | 116.5 Million INR | -3.99% |
| 2021 Q2 | 119.9 Million INR | 17.4% |
| 2021 Q1 | 102.13 Million INR | 75.66% |
| 2021 Q3 | 115.47 Million INR | -3.69% |
| 2021 FY | 109.85 Million INR | 88.94% |
| 2021 Q4 | 109.85 Million INR | -4.87% |
| 2020 Q1 | 89.99 Million INR | -0.45% |
| 2020 Q3 | 67.42 Million INR | -36.69% |
| 2020 Q4 | 58.14 Million INR | -13.76% |
| 2020 FY | 58.14 Million INR | 26.06% |
| 2020 Q2 | 106.49 Million INR | 18.34% |
| 2019 FY | 46.12 Million INR | -4.57% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 90.39 Million INR | 0.0% |
| 2019 Q2 | 87.25 Million INR | -11.98% |
| 2019 Q1 | 99.12 Million INR | 22.68% |
| 2018 Q4 | 80.8 Million INR | -4.78% |
| 2018 FY | 48.33 Million INR | -25.1% |
| 2018 Q3 | 84.86 Million INR | 2.18% |
| 2018 Q2 | 83.05 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 56.4 Million INR | 0.0% |
| 2017 Q4 | 81.85 Million INR | 0.0% |
| 2017 FY | 64.52 Million INR | 35.41% |
| 2016 Q2 | 66.75 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 65.82 Million INR | 0.0% |
| 2016 FY | 47.65 Million INR | -65.54% |
| 2015 Q4 | 138.31 Million INR | 0.0% |
| 2015 FY | 138.31 Million INR | 22.56% |
| 2014 FY | 112.85 Million INR | 11.67% |
| 2014 Q4 | 112.85 Million INR | 0.0% |
| 2013 Q2 | 51.5 Million INR | 3.79% |
| 2013 Q4 | 101.05 Million INR | 47.58% |
| 2013 Q1 | 49.62 Million INR | 6.01% |
| 2013 Q3 | 68.47 Million INR | 32.94% |
| 2013 FY | 101.05 Million INR | 115.88% |
| 2012 FY | 46.81 Million INR | 0.0% |
| 2012 Q4 | 46.81 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 14.13 Million INR | -936.093% |
| Checkpoint Trends Limited | - INR | -Infinity% |
| GUJARAT INJECT (KERALA) LTD. | - INR | -Infinity% |
| NATURO INDIABULL LIMITED | 13.22 Million INR | -1007.312% |
| NEXUS SURGICAL AND MEDICARE LI | - INR | -Infinity% |
| Rajnish Wellness Limited | 37.46 Million INR | -290.889% |
| Rama Vision Limited | 56.61 Million INR | -158.63% |
| Vivo Bio Tech Limited | 417.87 Million INR | 64.958% |